glp-1 vs sglt2 diabetes View of medications with cardiovascular protection after HARMONY Outcomes and DECLARE-TIMI 58: could metformin, pioglitazone, inhibitors and long-acting receptor agonists complement each other to save lives by different mechanisms? Mechanism of action of diabetes
Description
Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats
GLP-1 Vasodilatation in Humans with Coronary Artery Disease Is Not Adenosine Mediated
That means annual expenses may exceed $10,000 or more for patients paying full price
The studys authors retrieved this data from the CDCs NEISS-CADES database
The incidence rates of the 14 cancers were 13.6 vs 16.4 per 1000 person-years, respectively, indicating a significantly lower overall cancer risk among individuals taking GLP-1RAs (hazard ratio [HR], 0.83 [95% CI, 0.76-0.91]
2026;392:e085304 Wilding, J
